Children’s Minnesota’s pharmacy residency program offers opportunities for both first and second-year residents. The first year program is designed to provide residents with a wide variety of clinical and professional experiences in pediatrics. The second year program is designed to provide the residents with a year of more focused training in pediatrics.
About the PGY1 pharmacy practice residency
The PGY1 pharmacy practice residency is designed to provide the first-year resident with a wide variety of clinical and professional experiences in pediatrics. Residents will complete required rotations and have approximately three months to complete elective learning experiences in areas of their interest.
The purpose of our ASHP-accredited PGY1 residency program is to provide experience and knowledge which foster the development of skills to fulfill the challenges of evolving roles in pharmacy practice. Residents completing the pharmacy practice residency program at Children’s are able to:
- Manage and improve the medication-use process
- Exercise leadership and practice management skills
- Demonstrate project management skills
- Provide medication and practice-related education/training
- Utilize medical informatics
- Participate in the management of medical emergencies
- Demonstrate additional competencies that contribute to working successfully in the health care environment
Upon completion of this residency program, residency graduates are prepared to successfully fulfill the requirements of a clinical staff pharmacist working with pediatric patients in a clinical setting.
About the PGY2 pediatric specialty residency
The PGY2 pediatric specialty residency at Children’s Minnesota is designed to provide the second-year resident with a year of more focused training in pediatrics. The depending on the PGY2 resident’s prior experience, he/she will complete required rotations and will have greater flexibility to complete elective learning experiences in areas of their interest.
Residents will complete a residency project as well as participate in department initiatives, hospital committees and clinical educational programs for patients/families and hospital staff. In addition to on-site educational programs, residents also have the opportunity to teach in a pediatric pharmacotherapy course at the University of Minnesota.
The purpose of our ASHP-accreditation-pending PGY2 pediatric specialty residency program is to provide experience and knowledge which foster the development of skills to fulfill the challenges of evolving roles in pharmacy practice. Residents completing the pharmacy practice residency program at Children’s are able to:
- Demonstrate leadership and practice management skills in the pediatric patient care setting
- Optimize the care of inpatient and outpatient pediatric patients by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team
- Serve as an authoritative resource on the optimal use of medications used to treat pediatric patients
- Evaluate, manage and improve the medication-use process in pediatric patient care areas
- Demonstrate excellence in the provision of training or educational activities for pediatric health care professionals, health care professionals in training, and the public
- Conduct pediatric pharmacy research
- Demonstrate added skills for functioning effectively in the pediatric pharmacy practice environment
- Conduct outcomes research
- Demonstrate skills required to function in an academic setting
Upon completion of the PGY2 residency program, residency graduates are prepared to successfully fulfill the requirements of a pediatric pharmacy clinical specialist working with pediatric patients in a clinical setting. Graduates of this program will be qualified to serve as a clinical adjunct faculty for a college of pharmacy and be eligible for attainment of board certification in pediatrics.
Residents will be oriented to the department during the first week of the residency. This will consist of an overview of the department, introduction to department procedures, and opportunities to discuss work responsibilities with various department members.
The majority of training will occur during the first 5-6 weeks of the residency. It is expected that by the end of this time the resident will be competent to work on line shifts as a decentralized pharmacist at Children’s.
Residents may have the option to begin their orientation prior to July 1. Depending on when the resident begins their training, this could free up additional time for elective rotations later in the year.
Residency Learning Experiences
Individualized residency plan
We plan the learning experiences for the residency during the initial weeks of the residency year. The resident will complete a Resident Assessment and Plan for Training. Using this information, the resident’s primary preceptor will develop an individualized residency plan for the resident. Both the resident and the primary preceptor will agree to specific learning experiences.
Required learning experiences
The pharmacy practice residency program consists of required and elective learning experiences. The required learning experiences and their duration include:
- Orientation/training (5-6 weeks)
- Practice management (4 weeks followed by a longitudinal learning experience)
- Pediatric medicine (6 weeks)
- Pediatric intensive care (6 weeks)
- Neonatal intensive care (6 weeks)
- Staffing (Longitudinal learning experience)
- Residency project (Longitudinal learning experience)
- Teaching certificate (Longitudinal learning experience)
Elective learning experiences
The resident will have approximately 24 weeks for choosing elective learning experiences from either of Children’s hospital campuses to meet their interests. In the past, residents have chosen to pursue elective learning experiences in areas including (but not limited to): cardiovascular intensive care, inpatient/outpatient hematology, inpatient/outpatient oncology, epilepsy, medication therapy management, emergency medicine, pharmacogenomics, antibiotic stewardship, toxicology, cystic fibrosis and endocrinology. The resident may also choose to repeat a required rotation at either campus. It must be noted that the maximum amount of time the resident can spend in the same clinical area is four months. Off-site learning experiences outside Children’s Minnesota may also be available for the resident.
Evaluation of the resident’s performance is vital to the resident’s development and will consist of (at least) the following evaluations.
Summative evaluations are completed by the preceptor at the conclusion of the resident’s learning experience and quarterly during longitudinal learning experiences. Summative evaluations are designed to evaluate the resident’s performance on the goals and objectives assigned to their learning experiences.
Formative evaluations are related to specific events and tasks. It is precise feedback given at a specific moment in time after observing the resident’s activity. Formative feedback is usually given verbally by the preceptor. Formative evaluations may be completed as often as deemed necessary by the preceptor.
Residents conduct self-evaluation of their work on an ongoing basis. The preceptor will prepare a program of self-evaluation for the learning experience and discuss it with the resident.
Preceptor and learning experience evaluation
Upon completion of the learning experience, the resident shall complete the Preceptor and Learning Experience Evaluation form to provide feedback for the preceptor.
Residents’ progress towards accomplishing their residency goals will be assessed quarterly using the Quarterly Summary of Residency Goals form. This will help focus efforts towards the goals that the resident has not made significant progress in achieving.
Pharmacy Leadership Meeting
The Pharmacy Leadership Meeting is an informational meeting intended to keep management and clinical staffs current with department projects and up to date with recent developments in our department.
Pharmacy and Therapeutic Committee
The residents are appointed to the Pharmacy and Therapeutics Committee as non-voting members. Each PGY1 resident will write at least two new drug reviews and present this information to the committee for formulary inclusion or exclusion. The residents’ MUEs will also be approved and reviewed by the Pharmacy and Therapeutics Committee. The PGY2 resident will act in the role of committee secretary by taking minutes and working to set each month’s agenda.
Residents and preceptors will meet at least monthly to discuss current issues involving the residents and the residency program.
Clinical leader meetings
Residents will attend the monthly pharmacy clinical leader meeting to discuss clinical issues affecting the department and care of patients at Children’s.
National meetings (ASHP/PPAG/ACCP)
The department will pay for travel, lodging and meeting registration for one national meeting. PGY1 residents typically attend the PPAG Annual Meeting in late April and will present the results of their residency project at the meeting. In addition to the PPAG annual meeting, the PGY2 resident will also attend the ASHP Midyear Clinical Meeting.
Local professional meetings
Residents are strongly encouraged to attend local professional conferences that focus on current issues in pharmacotherapy. These would include the MSHP Annual and Midyear meetings.
The resident will be scheduled to provide four case presentations that meet requirements to qualify as CE credit with the Minnesota Board of Pharmacy. The topic of these presentations will be related to a current learning experience and will be presented via network link to both of Children’s – Minnesota’s hospital campuses. Preceptors of clinical rotations may also request the resident to present a case presentation or journal club at the end of their rotation.
The resident shall also provide didactic coursework for pharmacy students at the College of Pharmacy.
PGY1 residents and PGY2 residents who have not completed a teaching certificate will complete a teaching certificate during their residency year. The certificate is modeled on recommendations published by ACCP and includes large group didactic instruction, small group discussion and precepting.
Each resident completes a research or major project as part of their residency training. Each resident will work with their preceptor in the selection of their project. The results of this project are presented by the resident at the Annual Meeting of the Pediatric Pharmacy Advocacy Group. Assistance in research design is provided by Children’s Research Sponsored Programs in planning the project.
Adverse Drug Report Review
Each resident will be responsible for maintaining the adverse drug report log.
Medication Use Evaluation (MUE)
Each resident will be responsible for developing, performing and presenting a MUE project during their residency. The results will be presented at the Pharmacy and Therapeutics Committee and/or the medical division committee.
Each resident class is encouraged to tour different hospitals and pharmacy departments during the year. The purpose of these activities is to see alternative pharmacy systems and gain additional depth in knowledge and understanding in the provision of pharmacy services.
Resident Salary and Benefits
Residents get salary and benefits for residency activities through Children’s Minnesota. The stipend is competitive. Dental and health insurance is provided in the benefits package offered by Children’s.
Residents will have 30 days of paid time off during the residency year. Residents will deduct compensation time, education time, sick time, etc., from their PTO account. The resident will need to notify their primary preceptor and staffing coordinator in advance regarding vacation requests.
Pharmacy practice residents will be scheduled to work every other weekend throughout the residency. In St. Paul, residents work five out of 12 weekends due to an occasional 12-hour shift. Each resident can expect to work either the Christmas or New Year’s holiday and additional holidays consistent with staffing patterns for the department.
- David Hoff, PharmD, BCPPS, FCCP
- Julie Most, PharmD, MBA
- Paul Jensen, PharmD, BCPPS
- Julie Palmquist, BSPharm
- Joan Erickson, BSPharm
- Katie Meyers, PharmD, BCPPS
- Jessica Benshoof, PharmD, BCPS, BCPPS
- Lisa Stay, PharmD, BCPPS
- Polina Lipnik, PharmD, BCPPS
- Amy Gisslen, PharmD
- Mary Gustafson, PharmD, BCPS
- Jill Johnson, PharmD, BCPPS
- Kim Maxa, PharmD, BCOP
- Teresa Mansur, PharmD, BCPPS
- David Gregornik, PharmD, BCOP
- Kati Munson, PharmD
- Fan Zhang, PharmD, BCPPS
- Raylesha Creighton-Lewis, PharmD, BCACP, BCPPS
PGY1 pharmacy residents
Alexanna Gluck is originally from Waconia, Minnesota. She completed her pharmacy school prerequisites as well as her Doctor of Pharmacy from the University of Minnesota.
Alexanna’s practice interests include pediatric critical care and emergency medicine. Her residency research project for the year will focus on the toxicities of pegaspargase. Upon completion of her PGY1, Alexanna plans to pursue a PGY2 in pediatrics to expand her pediatric critical care knowledge. Her interests outside of pharmacy include rollerblading, running, embroidery, and spending time with friends and family.
Danielle Morgan is originally from Elk River, Minnesota. She received her Bachelor of Science in Biomedical Sciences with a minor in Spanish as well as a minor in Clinical and Applied Movement Science from the University of North Florida. She received her Doctor of Pharmacy degree along with a Certificate in Personalized Medicine from the University of Florida.
Danielle’s practice interest areas include critical care, emergency department, and toxicology. Her residency research project for the year will focus on ketorolac dosing optimization in the pediatric emergency department. Upon completion of her PGY1, Danielle plans to obtain a PGY2 in pediatrics to further develop her pediatric critical care knowledge base. Danielle’s interests outside of pharmacy include spending time with her nephew in Wisconsin, enjoying the Minnesota lake life, or catching some rays whether that be in Minnesota or Florida. She is also a big sports fan, with her favorites being the Minnesota Wild, the Minnesota Vikings, as well as the Florida Gators.
Courtney Paetznick is originally from Pine Island, Minnesota. She received her Bachelor of Science in Biochemistry with a minor in Business Administration from University of St. Thomas, St. Paul, MN and her Doctor of Pharmacy from University of Minnesota College of Pharmacy, Minneapolis, MN.
Courtney’s practice interest areas include pharmacogenomics, critical care, and infectious disease. Her residency research project for the year will focus on the evaluation of prescriber adherence to pharmacogenomic recommendations pre- and post-implementation of the Pharmacogenomics Program at Children’s Minnesota. Upon completion of her PGY1, Courtney plans to pursue a PGY2 in Clinical Pharmacogenomics with admiration to help expand individualized medicine through the use of pharmacogenomic information. Courtney’s interests outside of pharmacy includes outdoor activities (walking, biking, hiking, etc.), traveling, trying new restaurants (in search of the best fried chicken sandwich), and spending time with her husband, family, and friends.
Pediatric PGY2 resident
Meagan Balding is from Pensacola, Florida. She received her Bachelor of Science in Chemistry with a minor in Applied Mathematics from Jacksonville University and her Doctor of Pharmacy from the University of Florida College of Pharmacy. She completed her PGY1 Pharmacy Residency at Studer Family Children’s Hospital in Pensacola, Florida.
Meagan’s practice areas of interest include pediatric critical care and emergency medicine. Upon completion of her PGY2, she plans on practicing as a clinical pediatric pharmacist in a critical care setting. Meagan enjoys spending time with friends and family in her free time and looks forward to learning how to adapt to living in a new climate.
Pharmacogenomics PGY2 resident
Tyler Stevens is the PGY2 Clinical Pharmacogenomics resident at Children’s Minnesota. His residency is focused on both enhancing clinical skills in pharmacogenomics and developing expertise in clinical implementation of pharmacogenomics. Tyler is a graduate of the University of the University of Minnesota College of Pharmacy, completing his coursework from the Duluth campus. Prior to his residency at Children’s Minnesota, Tyler completed an ambulatory care focused PGY-1 Pharmacy Practice residency at CentraCare St. Cloud through the University of Minnesota College of Pharmacy Residency Program.
Tyler’s residency research project this year will be an examination of pharmacogenomics genes that may impact response to fluoxetine. After completing his PGY2, Tyler plans to continue practicing clinical pharmacogenomics and with his sights set on leading his own practice.
To apply for our residency program, you must:
Complete and submit the following to the PhORCAS website:
- Curriculum vitae
- Letters of reference from three individuals
- College of pharmacy transcripts
The completed application and curriculum vitae must be received by December 30.
Q: How many residents do you have?
A: Children’s currently accepts three PGY1 residents and one PGY2 resident. Two of the PGY1 residents and the PGY2 resident are officed and complete their staffing commitments on the Children’s – Minneapolis campus. One PGY1 resident is officed and completes his/her staffing on the Children’s – St. Paul campus. Note that each campus has a separate match number.
Q: When are applications due?
A: Applications need to be uploaded to the PhORCAS website by December 30. See the application tab for information on the application process.
Q: What happens after I submit my application?
A: Children’s residency preceptors will review all applications and will notify applicants of their status. Some applicants may be placed on an alternate list if the number of candidates exceeds the number of interview slots.
Q: How is the program designed?
A: The program is structured to provide you with an initial orientation/training module followed by core rotations and 24 weeks of elective rotations. See the overview tab for more information.
Q: What experiences are required?
A: The required learning experiences include:
- Practice management
- Pediatric medicine
- Pediatric intensive care
- Neonatal intensive care
- Residency Project
- Teaching Certificate
Q: What electives are available?
A: In the past, residents have chosen to pursue elective learning experiences in areas including (but not limited to): cardiovascular intensive care, inpatient/outpatient hematology, inpatient/outpatient oncology, epilepsy, medication therapy management, emergency medicine, pharmacogenomics, antibiotic stewardship, toxicology, cystic fibrosis and endocrinology. Off-site learning experiences outside Children’s may also be available for the resident.
Q: How are residents evaluated?
A: Residents are evaluated using the residency Accreditation Standards from ASHP.
Q: Is research required?
A: Yes, each resident shall complete a research or major project as part of their residency training.
Q: What teaching opportunities exist?
A: Residents will be scheduled to provide quarterly CE presentations to the pharmacy staff. The topic of these presentations will be related to their current learning experience. In addition to these presentations, the resident may give case presentations at the conclusion of clinical rotations. The resident also has the option of providing didactic coursework for pharmacy students at the College of Pharmacy. Residents may also assist with the preceptorship of pharmacy students on rotation at Children’s throughout the year.
Q: Is staffing required?
A: The PGY1 pharmacy practice residents will be scheduled to work every other weekend throughout the residency. In St. Paul, residents work five out of 12 weekends due to an occasional 12-hour shift. Each PGY1 resident can expect to work either the Christmas or New Year’s holiday and additional holidays consistent with staffing patterns for the department. The PGY2 pediatric specialty resident will staff every third weekend throughout the residency. In addition to staffing responsibilities, residents will also be assigned a nursing unit/or department as liaison pharmacist.
Q: Must I be licensed?
A: All pharmacy residents are required to be licensed in the State of Minnesota within 90 days of starting the residency.
Q: How do I get licensed?
A: Information regarding pharmacy licensure in Minnesota can be found at the Board of Pharmacy’s website.
Q: What is the salary?
A: Residents receive their salary and benefits for residency activities through Children’s Minnesota. The stipend varies by role. Dental and health insurance is provided in the benefits package offered by Children’s.
Q: How much vacation time is there?
A: Residents will accrue 30 days of paid time off during the residency year. Residents will deduct compensation time, education time, sick time, etc., from their PTO account. The resident will need to notify their primary preceptor and staffing coordinator in advance regarding vacation requests.
Have questions about the pharmacy residency program at Children's?